PPMA demands effective measures by Government to help increase drug exports

Print

 PPMA demands effective measures by 
Government to help increase drug exports

Pakistan Pharmaceutical Manufacturers Association (PPMA) has demanded the government to establish on emergency basis a one-window operation at the federal level and in provincial capitals to ease up all bureaucratic procedures and hurdles faced by pharma industry in enhancing exports.

This consensus demand was made by speakers at a seminar on the issue of exports by pharmaceutical industry of the country held here recently. The seminar was organized by the PPMA with the backdrop that annual exports of Pakistani pharmaceutical companies had dropped to alarming level of 200 million US Dollars. While the industry has now aimed to increase its exports to 05 billion Dollars in next five years despite stiff competition from drug manufacturers of the neighbouring countries, it seeks special incentives and measures from the government. It was also suggested to establish Pakistan-level Pharma Export Council for boosting exports of medicines from the country in order to compete with drug manufacturers of the regional countries.

Speaking on the occasion, Central Chairman of PPMA Dr. Kaiser Waheed said it was high time that the Drug Regulatory Authority of Pakistan (DRAP) should completely waive or significantly decrease fee for all sorts of documentation and procedures required for drug exports. He said the proposed one-window operations required for exports of drugs should grant all necessary permissions and get issued no-objection certificates from relevant state agencies in least possible time preferably in a single day. It should also oversee and look after all exports related operations of the pharmaceutical industry. DRAP should be made fully autonomous so that it can take up issues of drug registration speedily and facilitate drugs exports.

It was also pointed out that billions of rupees had been lying unused in Central Research Fund maintained by Health ministry as Pharma companies had been contributing one per cent of their profits towards this fund since 1976 for doing research for development of new medicines. The industry on alternative basis should get access to this fund for purely utilizing the unused finances for its growth especially from point of view of exports-related requirements.

State Minister for National Health Services, Regulations, and Coordination Saira Afzal Tarar who was chief guest on the occasion assured the participants of the seminar to give due consideration to their proposals for enhancing  drugs exports from the country.(PR)

© Professional Medical Publications. All rights reserved.